
Newt Gingrich discusses the Republican approach to affordability and the situation in Iran as part of his series on winning the 2026 campaign.
In Part Three of his "How to Win 2026" series, Newt Gingrich tackles the two hardest arguments in the entire 2026 campaign: the economy and Iran. On affordability, Newt makes the Republican case with specific facts and dollar figures: the steepest drop in prescription drug prices in sixty years, GLP-1 medications now available for $149 a month through TrumpRx, $82 billion in individual tax relief claimed in a single filing season, and concrete steps already underway on housing, energy, and regulation. On Iran, Newt is equally direct — the war has not gone as planned, the Iranian regime has proven more determined than expected, and there is no easy exit. But backing down, he argues, means gambling that a regime chanting "death to America" won't eventually make good on it. See omnystudio.com/listener for privacy information.
Host: Newt Gingrich
Organizations: TrumpRx
Places: Iran
Explore listener stats, chart rankings, contacts and more on the Newt's World podcast page.